H.R. 5074 · 118th Congress (2023–2025)
Kidney PATIENT Act of 2023
This bill delays a change to the payment methodology under Medicare for oral drugs that are used to treat end-stage renal disease (ESRD).
Under current regulations, beginning January 1, 2025, the Centers for Medicare & Medicaid Services will incorporate payments for oral-only ESRD drugs into the ESRD prospective payment system rather than issuing separate payments to ESRD facilities. The bill delays implementation of this policy until January 1, 2033, or until an approved intravenous drug is available, whichever is earlier.
Show official title
To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReported by committee
This bill’s path
This is H.R. 5074’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Earl L. "Buddy" Carter (R-GA-1)
- Cosponsors
45 cosponsors
3 original · 42 later
12 R · 33 D
- Rep. Ann M. Kuster (D-NH-2)· Original · Jul 28, 2023
- Rep. Carol D. Miller (R-WV-1)· Original · Jul 28, 2023
- Rep. Terri A. Sewell (D-AL-7)· Original · Jul 28, 2023
- Rep. Donald G. Davis (D-NC-1)· Later · Oct 6, 2023
- Rep. Yvette D. Clarke (D-NY-9)· Later · Nov 8, 2023
- Rep. John Joyce (R-PA-13)· Later · Nov 13, 2023
- Rep. Danny K. Davis (D-IL-7)· Later · Nov 17, 2023
- Rep. A. Drew Ferguson IV (R-GA-3)· Later · Nov 17, 2023
- Rep. Blake D. Moore (R-UT-1)· Later · Nov 30, 2023
- Rep. Henry Cuellar (D-TX-28)· Later · Dec 4, 2023
- Rep. Jodey C. Arrington (R-TX-19)· Later · Dec 19, 2023
- Rep. Henry C. "Hank" Johnson, Jr. (D-GA-4)· Later · Jan 29, 2024
- Rep. Larry Bucshon (R-IN-8)· Later · Mar 20, 2024
- Rep. William R. Keating (D-MA-9)· Later · Jul 9, 2024
- Rep. Stephen F. Lynch (D-MA-8)· Later · Jul 11, 2024
- Rep. Jonathan L. Jackson (D-IL-1)· Later · Jul 22, 2024
- Rep. Seth Moulton (D-MA-6)· Later · Jul 24, 2024
- Rep. Jasmine Crockett (D-TX-30)· Later · Jul 30, 2024
- Rep. Vince Fong (R-CA-20)· Later · Jul 30, 2024
- Rep. Mike Thompson (D-CA-4)· Later · Aug 30, 2024
- Rep. David G. Valadao (R-CA-22)· Later · Sep 3, 2024
- Rep. Michelle Steel (R-CA-45)· Later · Sep 9, 2024
- Rep. Eric Swalwell (D-CA-14)· Later · Sep 10, 2024
- Rep. Troy A. Carter (D-LA-2)· Later · Sep 17, 2024
- Rep. Adriano Espaillat (D-NY-13)· Later · Sep 24, 2024
- Rep. Veronica Escobar (D-TX-16)· Later · Sep 24, 2024
- Rep. Maxine Waters (D-CA-43)· Later · Oct 1, 2024
- Rep. Patrick Ryan (D-NY-18)· Later · Oct 4, 2024
- Rep. Thomas R. Suozzi (D-NY-3)· Later · Oct 4, 2024
- Rep. Gabe Vasquez (D-NM-2)· Later · Oct 4, 2024
- Rep. Hillary J. Scholten (D-MI-3)· Later · Oct 8, 2024
- Rep. Mary Sattler Peltola (D-AK)· Later · Oct 11, 2024
- Rep. Emilia Strong Sykes (D-OH-13)· Later · Oct 11, 2024
- Rep. Vicente Gonzalez (D-TX-34)· Later · Oct 18, 2024
- Rep. Steven Horsford (D-NV-4)· Later · Oct 18, 2024
- Rep. Gregory W. Meeks (D-NY-5)· Later · Oct 18, 2024
- Rep. Nydia M. Velázquez (D-NY-7)· Later · Oct 18, 2024
- Rep. Ritchie Torres (D-NY-15)· Later · Oct 25, 2024
- Rep. Young Kim (R-CA-40)· Later · Nov 5, 2024
- Rep. Jahana Hayes (D-CT-5)· Later · Nov 14, 2024
- Rep. Chellie Pingree (D-ME-1)· Later · Nov 14, 2024
- Rep. Linda T. Sánchez (D-CA-38)· Later · Nov 21, 2024
- Rep. John R. Curtis (R-UT-3)· Later · Dec 3, 2024
- Rep. Richard Hudson (R-NC-9)· Later · Dec 11, 2024
- Rep. Gabe Amo (D-RI-1)· Later · Dec 17, 2024
- Policy area
- Health
- Subjects
- Digestive and metabolic diseases
- Health care costs and insurance
- Medicare
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 9 committee actions · Jul 28, 2023 – Jun 11, 2024
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Markup session held
Committee Consideration and Mark-up Session Held
Sources
- Congress.gov action
- House committee actions
Ordered reported
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 1.
Sources
- Congress.gov action
- House committee actions
Subcommittee markup session held
Subcommittee Consideration and Mark-up Session Held
Sources
- Congress.gov action
- House committee actions
Forwarded by subcommittee
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 16 - 10.
Sources
- Congress.gov action
- House committee actions
Markup session held
Committee Consideration and Mark-up Session Held
Sources
- Congress.gov action
- House committee actions
Ordered reported
Ordered to be Reported (Amended) by the Yeas and Nays: 37 - 10.
Sources
- Congress.gov action
- House committee actions
Reported by committee
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.
Sources
- Congress.gov action
- House floor actions
Expired
Introduced → Reported by committee → No further action before the 118th Congress ended.
Committees
Mar 20, 2024 · Markup
Mar 12, 2024 · Markup
Sep 19, 2023 · Meeting
- HouseWays and MeansReferred Jul 28, 2023 · Markup Mar 6, 2024 · Reported Jun 11, 2024H. Rept. 118-548
Mar 6, 2024 · Markup
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
Kidney PATIENT Act of 2023
Display title, Short title · Introduced in House
Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023
Short title · Introduced in House
To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system.
Official title · Introduced in House